Replies to post #141 on KORU Medical Systems Inc (KRMD)

[blue_skies]

BUYOUT?? DOUBTFUL! UNLESS

I do not see a buyout this calendar year. UNLESS Joe Manko/Horton Management wants a buyout and that I very much doubt. Craig-Hallum raised the target price for the shares to $8. Manko and company would want over $10/share.

Dark clouds/black swan events are always a possibility. A surprise verdict in the EDEM case in the Californian courts? A lot of the subcutaneous infusion drugs are plasma derived and there are always possibilities of shortages or contamination issues?

More realistically I suspect that some of the newer cancer therapies will migrate to subcutaneous infusions? Why?? See link hyping subq infusions. Sometimes a story tells more then a narrative!!

https://lamberteatonnews.com/2020/01/29/subcutaneous-treatment-immunoglobulin-g-igg-ivig/